Michael Aguilar

Title: Michael Aguilar: Innovator in Opioid Impairment Simulation

Introduction

Michael Aguilar is an accomplished inventor based in Verona, WI (US). He has made significant contributions to the field of technology with a focus on simulating the effects of opioid impairment. With a total of 2 patents, Aguilar's work aims to enhance understanding and awareness of opioid-related effects through innovative eyewear devices.

Latest Patents

Aguilar's latest patents include a "System and method for simulating opioid impairment using an eyewear device." This system is designed to demonstrate the effects of opioid compounds to users. The eyewear device features at least one lens with an overlay that partially obscures the peripheral region. The lens includes multiple independently-controllable regions that can switch between different levels of opacity. A processor communicates with the eyewear device, executing instructions stored in memory to control the opacity levels effectively.

Another notable patent is the "System and method for simulating opioid impairment." This patent shares similar features with the previous one, emphasizing the importance of visual simulation in understanding opioid effects. The innovative design of the eyewear device allows for a more immersive experience, providing users with a realistic demonstration of impairment.

Career Highlights

Throughout his career, Michael Aguilar has worked with various companies, including Innocorp, Ltd. His experience in these organizations has contributed to his expertise in developing cutting-edge technologies related to health and safety.

Collaborations

Aguilar has collaborated with notable individuals such as Timothy Jorgensen and Debra C Kusmec-Aguilar. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Michael Aguilar stands out as an innovative inventor dedicated to addressing the challenges posed by opioid impairment through technology. His patents reflect a commitment to enhancing public understanding of opioid effects, making significant strides in the field.